Global Bioactive Peptide Market: Key Developments
Increasing research and development by key market players in the global bioactive peptide market is expected to drive the global bioactive peptide market over the forecast period. For instance, in September 2020, NeoMatrix Therapeutics, Inc., a clinical-stage company, announced positive topline data from its Phase 1 clinical trial of NMT-cP12, a bioactive peptide for intravenous treatment of burns within 2 to 4 hours of injury.
Furthermore, increasing number of inorganic strategies such as product launch by market players is expected to drive growth of the global bioactive peptide market over the forecast period. For instance, Rousselot, a collagen-based solutions, announced the launch of MSC-certified (Marine Stewardship Council) marine collagen peptides, Peptan, at Beauty & Skincare Formulation Conference 2021, which is made up of wild-caught marine white fish and certified by the Marine Stewardship Council (MSC) to help beauty and nutrition brands differentiate and expand their portfolio in nutria-cosmetics and dietary supplements.
Bioactive Peptide Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients